PharMerica (PMC) Tops Q2 EPS by 2c; Rev Guidance Lowered
Tweet Send to a Friend
PharMerica (NYSE: PMC) reported Q2 EPS of $0.32, $0.02 better than the analyst estimate of $0.30. Revenue for the quarter came in at $458.5 million versus the consensus estimate of $488.48 million.
FY12 Revenue Guidance Lowered
For earnings history and earnings-related data on PharMerica (PMC) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
FY12 Revenue Guidance Lowered
For earnings history and earnings-related data on PharMerica (PMC) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Abercrombie & Fitch Co. (ANF) Misses Q1 EPS by 4c; Guides FY Below Views
- Pandora (P) Pops Higher on Q1 Results; Expands Listener Base by 2.5M Subs
- Gap, Inc. (GPS) Tops Q1 EPS by 2c; Reaffirms Outlook
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
